Working on the legacy of Sir Dugald Baird who with Betty MacGregor introduced organised cervical screening in Grampian in the 1950's, 30 years before the UK programme. We have a long established programme of clinical trials (Birthright and TOMBOLA trials) which have informed UK and overseas screening programmes. Important outcomes have included disbenefits and after effects.
The AWCHR both leads and collaborates on National research programmes aimed at the prevention of cervical cancer thrugh HPV vaccination and optimal uptake of cervical screening. We are working with WHO to provide real world data on the achievable impacts of HPV vaccination and published one of the "most mentioned research papers" in 2019.
Key research areas:
- Human Papilloma Virus (HPV) immunisation and impact on cervical non-cervical HPV disease as well as other health outcomes
- Modelling different screening approaches based on risk to enhance benefits and reduce unnecessary intervention in HPV immunised women and ensure high quality and accessible colposcopy services
- Identification of new biomarkers for screening of HPV immunised women
- Identification of new biomarkers for screening of older non-immunised women